标题
Vasopressin Receptor Antagonists
作者
关键词
Arginine vasopressin, Vasopressin receptor V1a, Vasopressin receptor V1b, Vasopressin receptor V2, Aquaporin, Tolvaptan, Conivaptan, Hyponatremia, Syndrome of inappropriate antidiuretic hormone secretion (SIADH), Potassium, Congestive heart failure, Cirrhosis, Polycystic kidney disease, Osteoporosis, Endolymphatic hydrops
出版物
CURRENT HYPERTENSION REPORTS
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-01-21
DOI
10.1007/s11906-014-0510-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Isn’t It Ironic? Cost-Effectiveness and Willingness to Pay for Tolvaptan in the Prevention of Kidney Failure in Autosomal Dominant Polycystic Kidney Disease
- (2014) Robert Nee et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Conivaptan for Treatment of Hyponatremia in Neurologic and Neurosurgical Adults
- (2014) Mitchell S. Buckley et al. ANNALS OF PHARMACOTHERAPY
- Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1Breceptor antagonists: TASP0233278 and TASP0390325
- (2014) M Iijima et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload
- (2014) Koichiro Kinugawa et al. CIRCULATION JOURNAL
- Vasopressin-2 Receptor Signaling and Autosomal Dominant Polycystic Kidney Disease: From Bench to Bedside and Back Again
- (2014) M. M. Rinschen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
- (2014) Brian P. Baur et al. PHARMACOTHERAPY
- Cardiorenal Syndrome
- (2014) Claudio Ronco et al. Heart Failure Clinics
- Role of Vaptans in the Management of Hyponatremia
- (2013) Ruediger W. Lehrich et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations
- (2013) Joseph G. Verbalis et al. AMERICAN JOURNAL OF MEDICINE
- Role of vasopressin in maintenance of potassium homeostasis in severe hemorrhage
- (2013) Catherine F. T. Uyehara et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
- (2013) Kevin F. Erickson et al. ANNALS OF INTERNAL MEDICINE
- Use of conivaptan for management of hyponatremia following surgery for Cushing's disease
- (2013) Jonathan D. Breshears et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Renoprotective Effect of Vasopressin V2 Receptor Antagonist Tolvaptan in Dahl Rats With End-Stage Heart Failure
- (2013) Mayuko Ishikawa et al. International Heart Journal
- Hyponatremia in Heart Failure: Time for a Trial
- (2013) Steven R. Goldsmith JOURNAL OF CARDIAC FAILURE
- Clinical Course of Patients With Hyponatremia and Decompensated Systolic Heart Failure and the Effect of Vasopressin Receptor Antagonism With Tolvaptan
- (2013) Paul J. Hauptman et al. JOURNAL OF CARDIAC FAILURE
- Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease
- (2013) V. E. Torres et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
- (2013) Wendy E. Boertien et al. KIDNEY INTERNATIONAL
- Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function
- (2013) Susan E. Shoaf et al. KIDNEY INTERNATIONAL
- Vasopressin infusion into the lateral septum of adult male rats rescues progesterone-induced impairment in social recognition
- (2013) M.E. Bychowski et al. NEUROSCIENCE
- Tolvaptan therapy for massive edema in a patient with nephrotic syndrome
- (2013) Masaki Shimizu et al. PEDIATRIC NEPHROLOGY
- Therapeutic Effect of Conivaptan Bolus Dosing in Hyponatremic Neurosurgical Patients
- (2013) Paul E. Marik et al. PHARMACOTHERAPY
- Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia
- (2013) R. Tamma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mice Genetically Deficient in Vasopressin V1a and V1b Receptors Are Resistant to Jet Lag
- (2013) Yoshiaki Yamaguchi et al. SCIENCE
- Rapid Correction Rate of Hyponatremia as an Independent Risk Factor for Neurological Complication Following Liver Transplantation
- (2013) Jeonghwan Lee et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Adenylyl Cyclase 6 Enhances NKCC2 Expression and Mediates Vasopressin-Induced Phosphorylation of NKCC2 and NCC
- (2012) Timo Rieg et al. AMERICAN JOURNAL OF PATHOLOGY
- An Elderly Patient with Chronic Hyponatremia
- (2012) T. Berl Clinical Journal of the American Society of Nephrology
- Lixivaptan: a vasopressin receptor antagonist for the treatment of hyponatremia
- (2012) Mitchell H. Rosner KIDNEY INTERNATIONAL
- Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia
- (2012) William T. Abraham et al. KIDNEY INTERNATIONAL
- Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia
- (2012) William T. Abraham et al. KIDNEY INTERNATIONAL
- Synaptic innervation to rat hippocampus by vasopressin-immuno-positive fibres from the hypothalamic supraoptic and paraventricular nuclei
- (2012) L. Zhang et al. NEUROSCIENCE
- Aquaretic Treatment in Polycystic Kidney Disease
- (2012) Rudolf P. Wüthrich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
- (2012) Taka-aki Koshimizu et al. PHYSIOLOGICAL REVIEWS
- Enhanced glucose tolerance in the Brattleboro rat
- (2011) Kazuaki Nakamura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)
- (2011) Masunori Matsuzaki et al. CARDIOVASCULAR DRUGS AND THERAPY
- Tolvaptan for the Management of Syndrome of Inappropriate Antidiuretic Hormone Secretion: Lessons Learned in Titration of Dose
- (2011) Andrea Torres et al. Endocrine Practice
- The contributions of oxytocin and vasopressin pathway genes to human behavior
- (2011) Richard P. Ebstein et al. HORMONES AND BEHAVIOR
- Genes that escape from X inactivation
- (2011) Joel B. Berletch et al. HUMAN GENETICS
- Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis
- (2011) Andrés Cárdenas et al. JOURNAL OF HEPATOLOGY
- Aldosterone Requires Vasopressin V1a Receptors on Intercalated Cells to Mediate Acid-Base Homeostasis
- (2011) Y. Izumi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hyponatremia and bone: an emerging relationship
- (2011) Ewout J. Hoorn et al. Nature Reviews Endocrinology
- Calendar of Events
- (2011) Russell R Lonser NEUROSURGERY
- Treatment of hyponatremia
- (2010) Richard H Sterns et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis
- (2010) Florence Wong et al. JOURNAL OF HEPATOLOGY
- New horizons in the pharmacologic approach to hyponatremia: The V2 receptor antagonists
- (2010) Biff F. Palmer Journal of Hospital Medicine
- Potential of Nonpeptide (Ant)agonists to Rescue Vasopressin V2 Receptor Mutants for the Treatment of X-linked Nephrogenic Diabetes Insipidus
- (2010) E. L . Los et al. JOURNAL OF NEUROENDOCRINOLOGY
- Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
- (2010) T. Berl et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients
- (2010) Andrew M. Naidech et al. Neurocritical Care
- Endolymphatic Hydrops: Pathophysiology and Experimental Models
- (2010) Alec N. Salt et al. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
- Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
- (2009) Tadashi Okada et al. Clinical and Experimental Nephrology
- Both V1A and V1B vasopressin receptors deficiency result in impaired glucose tolerance
- (2009) Kazuaki Nakamura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Vasopressin regulation of blood pressure and volume: findings from V1a receptor–deficient mice
- (2009) Toshinori Aoyagi et al. KIDNEY INTERNATIONAL
- Effect of hyponatraemia on outcomes following orthotopic liver transplantation
- (2009) William A. Hackworth et al. LIVER INTERNATIONAL
- Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease
- (2009) Jacqueline G. O'Leary et al. LIVER TRANSPLANTATION
- Conivaptan Bolus Dosing for the Correction of Hyponatremia in the Neurointensive Care Unit
- (2009) Theresa Murphy et al. Neurocritical Care
- Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction
- (2008) James E. Udelson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started